<?xml version='1.0' encoding='utf-8'?>
<document id="18249085"><sentence text="Assessment of drug-drug interaction for silymarin."><entity charOffset="40-49" id="DDI-PubMed.18249085.s1.e0" text="silymarin" /></sentence><sentence text="Silymarin was assessed for drug-drug interaction by permeability studies with Caco-2 cells, for cytochrome P450 induction with human primary hepatocytes and for cytochrome P450 inhibition with human liver microsomes"><entity charOffset="0-9" id="DDI-PubMed.18249085.s2.e0" text="Silymarin" /></sentence><sentence text=" Studies with Caco-2 cells revealed no interference of silymarin with the permeability of nifedipine"><entity charOffset="55-64" id="DDI-PubMed.18249085.s3.e0" text="silymarin" /><entity charOffset="90-100" id="DDI-PubMed.18249085.s3.e1" text="nifedipine" /><pair ddi="false" e1="DDI-PubMed.18249085.s3.e0" e2="DDI-PubMed.18249085.s3.e0" /><pair ddi="false" e1="DDI-PubMed.18249085.s3.e0" e2="DDI-PubMed.18249085.s3.e1" /></sentence><sentence text=" Silymarin did not induce cytochromes P450 2C9 and 3A4 at concentrations of 0"><entity charOffset="1-10" id="DDI-PubMed.18249085.s4.e0" text="Silymarin" /></sentence><sentence text="1; 1; and 100 microM, measured as silibinin"><entity charOffset="34-43" id="DDI-PubMed.18249085.s5.e0" text="silibinin" /></sentence><sentence text=" The inhibitory effect was tested on the nine major cytochromes P450 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4 at concentrations of 1 and 100 microM silymarin"><entity charOffset="156-165" id="DDI-PubMed.18249085.s6.e0" text="silymarin" /></sentence><sentence text=" At 1 microM concentration no or negligible inhibition of cytochromes P450 1A2, 2A6, 2B6, 2C8, 2C9, and 2E1, minor inhibition of 3A4 (&lt;20%), and moderate inhibition of 2C19 and 2D6 (&lt;40%) were observed" /><sentence text=" Inhibition constant Ki of silymarin was determined for cytochromes P450 3A4 with 12 microM, 2C19 with 2 microM, and 2D6 with 12 microM"><entity charOffset="27-36" id="DDI-PubMed.18249085.s8.e0" text="silymarin" /></sentence><sentence text=" Only at the high concentration of 100 microM silymarin, inhibition at &gt;50% of the cytochromes P450 2B6, 2C8, 2C9, 2C19, 2D6, and 3A4 was observed, and no or moderate inhibition was for the cytochromes P450 1A2, 2A6, and 2E1"><entity charOffset="46-55" id="DDI-PubMed.18249085.s9.e0" text="silymarin" /></sentence><sentence text=" However, in view of the clinically relevant plasma concentration of approx" /><sentence text=" 0" /><sentence text="2 microM measured as silibinin, it is evident that there is no drug-drug interaction problem with silymarin"><entity charOffset="21-30" id="DDI-PubMed.18249085.s12.e0" text="silibinin" /><entity charOffset="98-107" id="DDI-PubMed.18249085.s12.e1" text="silymarin" /><pair ddi="false" e1="DDI-PubMed.18249085.s12.e0" e2="DDI-PubMed.18249085.s12.e0" /><pair ddi="false" e1="DDI-PubMed.18249085.s12.e0" e2="DDI-PubMed.18249085.s12.e1" /></sentence><sentence text="" /></document>